Subscribe to Newsletter

September 2015 Issue of The Medicine Maker

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Discovery & Development Clinical Trials

Clinical Trial Clarity

| Charlotte Barker

Drug makers and regulators are taking steps towards transparency, but is it enough?

Discovery & Development

Wasps Versus Cancer

Do Brazilian wasps hold the promise of a new anticancer therapy? The answer is in the sting

Manufacture Analytical Science

Quantum Leap in Real-time Monitoring?

| Stephanie Vine

Continuous monitoring of pharma products with an innovative matchbox-sized laser

Business & Regulation Business Practice

Fighting for Freedom of Speech

| Stephanie Vine

Drug companies claim that off-label drug promotion is protected by freedom of speech.

Manufacture Advanced Medicine

Antibody Attack

| Stephanie Vine

DNA vaccine helps turn patients’ own cells into antibody-producing factories.

Business & Regulation Business Practice

CPhI in Numbers

| Stephanie Vine

CPhI Worldwide 2015 in Madrid is just around the corner. Are you ready for showtime?

Discovery & Development Technology and Equipment

All Eyes on Antibiotics?

| Harparkash Kaur

More quality control testing is needed to ensure that antibiotics don't become targets for fraudsters.

Manufacture Technology and Equipment

The Redeployment Dilemma

Redeploying or selling equipment without sufficient expertise can lead to liability risks.

Manufacture Small Molecules

Fixing the Negative Perception of QbD

| Christoph Herwig

Knowledge managementof QbD can help bring benefits in medicine manufacture.

Manufacture Technology and Equipment

A New Dimension to Medicine Manufacture

| Stephanie Vine

The FDA approved the first 3D-printed drug in August; what other hot research projects are set to shape pharma’s 3D future?

Manufacture Technology and Equipment

Big Pharma’s 3D Focus

| Clive Roberts

Clive Roberts from the UK's University of Nottingham describes his team's work with big pharma on printing medicines.

Manufacture Technology and Equipment

From Pharma-Grade Filaments to Capsular Delivery Systems

Our research team has been investigating innovative manufacturing technologies to develop custom drug delivery systems, and one area of interest for us is 3D printing.

Manufacture Technology and Equipment

Appreciating the Potential of 3D Printing

| Stephanie Vine

Aprecia Pharmaceuticals has recently received the first FDA approval for a drug made with 3D printing technology.

Manufacture Technology and Equipment

Chemical Creations

| Lee Cronin

Lee Cronin is using 3D printing systems to perform some very clever and unique chemistry.

Manufacture Technology and Equipment

Bioprinting Better Drug Development

| Alan Faulkner-Jones

Parallel to the development of 3D printing, techniques have also been developed that can print living cells.

Manufacture Technology and Equipment

Thinking Outside the Pyramid

| Stephanie Vine

Earlier this year, a research group used 3D printing to give tablets a geometric makeover.

Manufacture Technology and Equipment

3D Printing 101

| Stephanie Vine

What is 3D printing? Our 101 class will get yopu up to speed with the basics and history of the technique.

Manufacture Technology and Equipment

Inkjet Innovation

| Stephanie Vine

Although our September cover feature focused on 3D printing, it is not the only printing technique that is being investigated in pharma applications.


The Trojan ADC Challenge

| Aad van de Leur

Often touted as ‘magic bullets’ against cancer, antibody-drug conjugates (ADCs) aim to combine the effectiveness of chemotherapy...

Business & Regulation Business Practice

Accepting R&D Failure

| Stephanie Vine

Learning when to abandon an R&D project can open the door to potential future gains.

Discovery & Development Clinical Trials

The Cautious Comeback of Oral Peptides

| David J. Brayden

Despite clinical failures in the 1990s, pharma is (cautiously) ready to try again with oral peptide formulations.

Business & Regulation Business Practice

How to Ace Interviews

Is it time to update your resume and fine-tune your interview skills?

Business & Regulation Business Practice

The Joy of Discovery

| Stephanie Vine

Sitting Down With... David Baltimore, Nobel Laureate, President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology, USA.

Manufacture Quality & Compliance

Getting Under the Skin of Extractables and Leachables

| Stephanie Vine

There are key benefits to having an industry standard for E&L studies – but a standard is only the beginning.

Other issues of 2015